Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis

NCT04620213 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Mydriasis
Dilation

Interventions

DRUG: Phentolamine Ophthalmic Solution 0.75%
OTHER: Phentolamine Ophthalmic Solution Vehicle (Placebo)

Sponsor

Ocuphire Pharma, Inc.